Bin Lan
Impact in
-
- Protease and Inhibitor Mechanisms
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 4
-
- T-cell and B-cell Immunology 3
- Co-authors
- Fang Guo (5 shared papers)Xuefeng Wang (5 shared papers)Yifeng Guo (2 shared papers)Chongyang Wei (2 shared papers)Biao Jiang (2 shared papers)Baowei Peng (2 shared papers)Desheng Lu (1 shared paper)Thomas S. Edgington (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Cell Research (2 papers)BMC Cancer (1 paper)Science Advances (1 paper)Immunobiology (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Bin Lan
27 papers receiving 400 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 75
- Oncology 77
- Genetics 16
- Molecular Biology 116
- Aging 3
Countries citing papers authored by Bin Lan
This map shows the geographic impact of Bin Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Lan more than expected).
Fields of papers citing papers by Bin Lan
This network shows the impact of papers produced by Bin Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Lan. The network helps show where Bin Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 91 | |
| 2 | 2020 | 52 | |
| 3 | 2023 | 43 | |
| 4 | 2021 | 35 | |
| 5 | 2015 | 30 | |
| 6 | 2018 | 27 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 16 | |
| 9 | 2016 | 15 | |
| 10 | Investigation of Leptin and its receptor (LEPR) for single nucleotide polymorphisms in colorectal cancer: a case-control study involving 2,306 subjects. | 2020 | 11 |
| 11 | 2021 | 8 | |
| 12 | 2015 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2018 | 6 | |
| 15 | [Polo like kinase 1 expression and prognostic value in gastric carcinomas]. | 2007 | 5 |
| 16 | 2023 | 5 | |
| 17 | 2025 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2025 | 4 | |
| 20 | 2025 | 4 |
About Bin Lan
Bin Lan is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Otorhinolaryngology, having authored 29 papers that have together received 402 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related Molecular Pathways (4 papers), Cell death mechanisms and regulation (4 papers), T-cell and B-cell Immunology (3 papers), Microtubule and mitosis dynamics (2 papers), Ultrasound and Hyperthermia Applications (2 papers), Genetic factors in colorectal cancer (2 papers) and Head and Neck Cancer Studies (2 papers). The work is most often cited by research in Cancer Research (75 citations), Oncology (77 citations), Genetics (16 citations), Molecular Biology (116 citations) and Aging (3 citations). Bin Lan has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Fang Guo, Xuefeng Wang, Yifeng Guo, Chongyang Wei, Biao Jiang, Baowei Peng, Desheng Lu, Thomas S. Edgington, Weifeng Tang and Yongming Qiu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cell Research, BMC Cancer, Science Advances and Immunobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.